![COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology | Nature Reviews Gastroenterology & Hepatology COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-021-00480-y/MediaObjects/41575_2021_480_Fig1_HTML.png)
COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology | Nature Reviews Gastroenterology & Hepatology
![Challenges and approaches for the development of safer immunomodulatory biologics | Nature Reviews Drug Discovery Challenges and approaches for the development of safer immunomodulatory biologics | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd3974/MediaObjects/41573_2013_Article_BFnrd3974_Fig1_HTML.jpg)
Challenges and approaches for the development of safer immunomodulatory biologics | Nature Reviews Drug Discovery
![Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: Usefulness of administrative data - ScienceDirect Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: Usefulness of administrative data - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S209012321830095X-ga1.jpg)
Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: Usefulness of administrative data - ScienceDirect
![Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis - ScienceDirect Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356520312817-fx1.jpg)
Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis - ScienceDirect
![Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom? - ScienceDirect Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2590257122000244-ga1.jpg)
Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom? - ScienceDirect
![PDF) Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting PDF) Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting](https://i1.rgstatic.net/publication/335769313_Adverse_Events_in_Patients_With_Rheumatoid_Arthritis_and_Psoriatic_Arthritis_Receiving_Long-Term_Biological_Agents_in_a_Real-Life_Setting/links/5d7a466d299bf1cb809b424e/largepreview.png)
PDF) Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting
![Considerable variation among Iranian dermatologists in the knowledge and attitudes regarding the use of biologic agents to manage psoriasis, - ScienceDirect Considerable variation among Iranian dermatologists in the knowledge and attitudes regarding the use of biologic agents to manage psoriasis, - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S235264751930111X-gr1.jpg)